.DOCX
1/1
The value of the accelerated approval pathway: Real-world outcomes associated with reducing the time between innovations - supplementary material
dataset
posted on 2024-01-23, 09:38 authored by William Wong, Stacey Kowal, Tu My To, Achal Patel, David Veenstra, Louis Garrison, Meng LiSupplementary table 1. Patient selection and attrition.
Supplementary table 2. Patient characteristics.
Supplementary table 3. Proportion of patients surviving to the AA date in real-world database and population level.
Supplementary figure
Funding
Genentech. Inc, (Grant / Award Number)
History
Usage metrics
Licence
Exports
RefWorksRefWorks
BibTeXBibTeX
Ref. managerRef. manager
EndnoteEndnote
DataCiteDataCite
NLMNLM
DCDC